LKT Labs

Biochemicals for Life Science Research

Crizotinib

Crizotinib

Product ID C6935
Cas No. 877399-52-5
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $74.90 In stock
10 mg $112.40 In stock
25 mg $247.30 In stock
100 mg $599.30 In stock
Bulk Quote

Quicklinks

Description

Crizotinib is an inhibitor of anaplastic lymphoma kinase (ALK), c-ros oncogene 1 (ROS1), and c-MET, binding competitively to the ATP-binding pocket of kinases. Crizotinib exhibits anticancer chemotherapeutic benefit in the treatment of non-small cell lung cancer (NSCLC) and is currently in clinical trials as a potential treatment for neuroblastoma and other advanced solid tumors. In cellular models, this compound upregulates expression of pro-apoptotic BIM and downregulates expression of anti-apoptotic survivin to induce apoptosis and inhibit cell proliferation.

Product Info

Cas No.

877399-52-5
Purity

≥98%
Formula

C21H22Cl2FN5O
Formula Wt.

450.34
IUPAC Name

3-[(1R)-1-(2, 6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl) pyridin-2-amine
Appearance

White to off white powder

Shipping and Storage

Store Temp

Ambient
Ship Temp

Ambient

Downloads

MSDS

C6935 MSDS PDF
Info Sheet

C6935 Info Sheet PDF

References

Timm A, Kolesar JM. Crizotinib for the treatment of non-small-cell lung cancer. Am J Health Syst Pharm. 2013 Jun 1;70(11):943-7. PMID: 23686600.

Okamoto W, Okamoto I, Arao T, et al. Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplification. Mol Cancer Ther. 2012 Jul;11(7):1557-64. PMID: 22729845.

Tanizaki J, Okamoto I, Okamoto K, et al. MET tyrosine kinase inhibitor crizotinib (PF-02341066) shows differential antitumor effects in non-small cell lung cancer according to MET alterations. J Thorac Oncol. 2011 Oct;6(10):1624-31. PMID: 21716144.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • A0025

    17-Allylaminogeldanamycin

    Geldanamycin derivative; HSP90 inhibitor.
    ≥97%
  • R3249

    Rimantadine Hydrochloride

    Viral M2 proton channel blocker.
    ≥98%
  • R5749

    Romidepsin

    HDAC inhibitor.
    ≥98%
  • A5134

    Aminophylline Anhydrous

    Adenosine antagonist, PDE inhibitor.
    ≥98%
  • I7659

    1-Isothiocyanato-8-(methylsulfonyl)-octane

    ITC, erysolin analog.
    ≥98%
  • O1176

    n-Octyl Caffeate

    Caffeic acid derivative.
    ≥98%
  • A7461

    Asperosaponin VI

    Triterpene saponin found in Dipsacus asper.
    ≥98%
  • C8070

    Curcumin, high purity

    Active compound found in turmeric; MST1 activator,...
    ≥98%
  • D5662

    Dopamine Hydrochloride

    Endogenous hormone neurotransmitter, involved in m...
    ≥99%
  • T6935

    Trimebutine Base

    BK K+ channel and L-type Ca2+ channel blocker.
    ≥97%
  • L8011

    D-Luciferin Sodium

    Heterocyclic light-emitting compound, natural liga...
    ≥99%
  • A4369

    A-K-R-R-R-L-S-S-L-R-A

    ROCK-2 substrate.
    ≥95%
  • G3357

    Ginkgolide C

    Diterpene lactone found in Ginkgo; GABA-A, α-1 Gl...
    ≥98%
  • E5217

    β-Endorphin, human

    Endogenous opioid peptide; μOR agonist.
    ≥95%
  • P0075

    P75-TNFR Peptide

    Peptide fragment of P75 TNF receptor.
    ≥95%
  • B6813

    Bradykinin Potentiator C

    Peptide found in Agkistrodon vipers; bradykinin in...
    ≥95%
  • T5608

    α-Tocotrienol

    Antioxidant, vitamin E derivative found in vegetab...
    ≥98%
  • A9435

    Axitinib

    VEGFR inhibitor.
    ≥98%
  • P2857

    Phorbol-12-myristate-13-acetate

    PKC activator, carcinogen.
    ≥98%
  • A4400

    Alamethicin

    Antimicrobial peptide found in Trichoderma, induce...
    ≥95%